Determinants of Long‐Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population‐Based Cohort Study

Journal of the American Heart Association - Tập 7 Số 16 - 2018
Jihad Mustapha1, Barry T. Katzen2, Richard F. Neville3, R. Lookstein4, Thomas Zeller5, Larry E. Miller6, Michael R. Jaff7
1Jihad A. Mustapha Advanced Cardiac & Vascular Amputation Prevention Centers, Grand Rapids, MI
2Barry T. Katzen Division of Interventional Radiology, Miami Cardiac and Vascular Institute, Miami, FL
3Richard F. Neville Division of Vascular Surgery, Department of Surgery, Inova Heart and Vascular Institute, Inova Fairfax Medical Campus, Falls Church, VA
4Robert A. Lookstein Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY
5Department of Angiology, Universitäts Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany
6Larry E. Miller Miller Scientific Consulting, Asheville, NC
7Newton Wellesley Hospital, Newton, MA

Tóm tắt

Background The optimal treatment for critical limb ischemia remains controversial owing to conflicting conclusions from previous studies. Methods and Results We obtained administrative claims on Medicare beneficiaries with initial critical limb ischemia diagnosis in 2011. Clinical outcomes and healthcare costs over 4 years were estimated among all patients and by first treatment (endovascular revascularization, surgical revascularization, or major amputation) in unmatched and propensity‐score–matched samples. Among 72 199 patients with initial primary critical limb ischemia diagnosis in 2011, survival was 46% (median survival, 3.5 years) and freedom from major amputation was 87%. Among 9942 propensity‐score–matched patients (8% rest pain, 26% ulcer, and 66% gangrene), survival was 38% with endovascular revascularization (median survival, 2.7 years), 40% with surgical revascularization (median survival, 2.9 years), and 23% with major amputation (median survival, 1.3 years; P <0.001 for each revascularization procedure versus major amputation). Corresponding major amputation rates were 6.5%, 9.6%, and 10.6%, respectively ( P <0.001 for all pair‐wise comparisons). The cost per patient year during follow‐up was $49 700, $49 200, and $55 700, respectively ( P <0.001 for each revascularization procedure versus major amputation). Conclusions Long‐term survival and cost in critical limb ischemia management is comparable between revascularization techniques, with lower major amputation rates following endovascular revascularization. Primary major amputation results in shorter survival, higher risk of subsequent major amputation, and higher healthcare costs versus revascularization. Results from this observational research may be susceptible to bias because of the influence of unmeasured confounders.

Từ khóa


Tài liệu tham khảo

10.1016/j.jacc.2016.11.007

10.1016/j.jvs.2015.09.063

10.1016/j.jcin.2016.09.039

10.1016/S0140-6736(05)67704-5

10.1080/13696998.2017.1361961

Peacock JM, Keo HH, Duval S, Baumgartner I, Oldenburg NC, Jaff MR, Henry TD, Yu X, Hirsch AT. The incidence and health economic burden of ischemic amputation in Minnesota, 2005–2008. Prev Chronic Dis. 2011;8:A141.

10.1001/jamainternmed.2015.0486

Agency for Healthcare Research and Quality . HCUP Databases. 2011. Available at: www.hcup-us.ahrq.gov/databases.jsp. Accessed October 9 2017.

Baser O, Verpillat P, Gabriel S, Wang L. Prevalence, incidence, and outcomes of critical limb ischemia in the US Medicare population. Vasc Dis Manage. 2013;10:26–36.

10.1161/CIRCOUTCOMES.111.962233

10.1214/aos/1176345976

Cox DR, Snell EJ. The Analysis of Binary Data. 2nd ed. London: Chapman & Hall; 1989.

10.1097/EDE.0b013e318289dedf

Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33–38.

10.1093/biomet/87.2.329

Social Security Administration . Retirement & Survivors Benefits: Life Expectancy Calculator. Available at: https://www.ssa.gov/OACT/population/longevity.html. Accessed August 27 2017.

10.1161/CIR.0000000000000350

10.1161/01.STR.31.9.2080

National Cancer Institute . Cancer Stat Facts. Available at: https://seer.cancer.gov/statfacts/. Accessed: August 27 2017.

10.1016/j.jvs.2006.12.037

10.1016/j.ahj.2012.12.002

10.1016/j.avsg.2011.07.014

Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Vivekananthan K, Mitran EV, Allie SE, Chaisson G, Stagg SJ, Allie AA, McElderry MW, Walker CM. Critical limb ischemia: a global epidemic. A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention. 2005;1:75–84.

10.1016/j.jvs.2013.07.114

10.1161/JAHA.116.003219

10.1161/CIR.0000000000000470

10.1177/1358863X14559589

Thông tin
Thông tin xuất bản

Journal of the American Heart Association

Tập 7 Số 16

Thông tin tác giả